Home> Products> hyperglycemia

{ "products": [ { "_id": "6a1974914d580c75a3c81fba", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nateglinide 60mg", "description": "Managing blood sugar levels is one of the most important steps in living a healthy life with diabetes. Nateglinide 60mg Tablets are commonly prescribed to help people with Type 2 Diabetes Mellitus maintain better glucose control, especially after meals. This medicine belongs to a class of drugs known as meglitinides, which help the pancreas release insulin quickly after eating.\n\nIf you are searching for a reliable medication to support post-meal sugar control, Nateglinide 60mg Tablets may be an effective option recommended by healthcare professionals. In this detailed guide, you will learn how Nateglinide works, its uses, benefits, dosage information, side effects, precautions, and why it is widely used in diabetes management.\n\nWhat Are Nateglinide 60mg Tablets?\n\nNateglinide 60mg Tablets are oral anti-diabetic medicines used to treat Type 2 Diabetes Mellitus. They are specifically designed to control the rise in blood sugar levels that occurs after meals.\n\nUnlike some diabetes medicines that work throughout the day, Nateglinide acts quickly and for a shorter duration. This helps mimic the body's natural insulin response after eating.\n\nDoctors often prescribe Nateglinide along with a healthy diet, regular exercise, and lifestyle changes to achieve optimal diabetes control.\n\nComposition of Nateglinide 60mg Tablets\n\nEach tablet contains:\n\nNateglinide – 60mg\n\nThis active ingredient stimulates the pancreas to release insulin immediately after meals, helping reduce postprandial blood sugar spikes.\n\nHow Does Nateglinide 60mg Work?\n\nNateglinide belongs to the meglitinide class of anti-diabetic medicines. It works by stimulating the beta cells of the pancreas to release insulin quickly after food intake.\n\nMechanism of Action\nHelps the pancreas release insulin rapidly\nControls blood sugar rise after meals\nImproves glucose metabolism\nReduces post-meal hyperglycemia\nHelps maintain overall glycemic control\n\nBecause it acts quickly, Nateglinide is usually taken before meals for maximum effectiveness.\n\nUses of Nateglinide 60mg Tablets\n1. Treatment of Type 2 Diabetes Mellitus\n\nThe primary use of Nateglinide 60mg Tablets is to manage blood sugar levels in adults with Type 2 Diabetes.\n\n2. Post-Meal Sugar Control\n\nIt is especially effective in controlling sudden blood sugar spikes that occur after eating.\n\n3. Combination Therapy\n\nDoctors may prescribe Nateglinide with:\n\nMetformin\nInsulin sensitizers\nOther anti-diabetic medications\n4. Lifestyle-Based Diabetes Management\n\nNateglinide works best when combined with:\n\nBalanced diet\nRegular physical activity\nWeight management\nHealthy lifestyle habits\nBenefits of Nateglinide 60mg Tablets\nFast Action After Meals\n\nOne of the biggest advantages of Nateglinide is its rapid onset of action. It begins working quickly after intake, helping manage post-meal glucose spikes effectively.\n\nBetter Blood Sugar Control\n\nConsistent use can help:\n\nLower blood sugar levels\nImprove HbA1c levels\nReduce fluctuations in glucose levels\nFlexible Meal-Time Dosing\n\nSince it is taken before meals, patients may find it easier to adjust according to their eating schedule.\n\nLower Risk of Long-Term Diabetes Complications\n\nGood blood sugar management may reduce the risk of:\n\nNerve damage\nKidney problems\nVision issues\nHeart disease\nSupports Healthy Daily Living\n\nBy controlling sugar levels efficiently, Nateglinide helps patients maintain better energy and overall wellness.\n\nWhy Doctors Prescribe Nateglinide 60mg Tablets\n\nHealthcare professionals commonly prescribe Nateglinide because it offers:\n\nQuick insulin release\nEffective post-meal sugar control\nConvenient dosing\nGood compatibility with other diabetes medications\nImproved patient compliance\n\nIt is especially beneficial for patients who experience high blood sugar after meals despite diet control.\n\nDosage and Administration\nRecommended Dosage\n\nThe dosage depends on:\n\nBlood sugar levels\nMedical history\nOther medications\nDoctor’s recommendation\nGeneral Instructions\nUsually taken 1 to 30 minutes before meals\nSwallow with water\nDo not skip meals after taking the tablet\nFollow your doctor’s prescribed schedule carefully\n\nIf a meal is skipped, the dose may also need to be skipped to avoid low blood sugar.\n\nWho Should Use Nateglinide 60mg Tablets?\n\nNateglinide may be recommended for:\n\nAdults with Type 2 Diabetes\nPatients needing postprandial glucose control\nIndividuals not adequately controlled through diet and exercise alone\n\nHowever, it should only be used under medical supervision.\n\nWho Should Avoid Nateglinide?\n\nAvoid using Nateglinide without consulting a healthcare provider if you have:\n\nType 1 Diabetes\nSevere liver disease\nDiabetic ketoacidosis\nAllergy to Nateglinide\nFrequent hypoglycemia episodes\n\nPregnant and breastfeeding women should consult their doctor before use.\n\nSide Effects of Nateglinide 60mg Tablets\n\nLike all medicines, Nateglinide may cause some side effects. Most are mild and manageable.\n\nCommon Side Effects\nLow blood sugar (hypoglycemia)\nDizziness\nHeadache\nWeakness\nSweating\nTremors\nStomach discomfort\nSerious Side Effects\n\nSeek medical attention if you experience:\n\nSevere allergic reactions\nDifficulty breathing\nSevere hypoglycemia\nUnusual fatigue\nYellowing of skin or eyes\nSymptoms of Low Blood Sugar\n\nBecause Nateglinide increases insulin release, low blood sugar may occur, especially if meals are skipped.\n\nCommon Symptoms Include:\nHunger\nShaking\nFast heartbeat\nSweating\nConfusion\nBlurred vision\n\nKeep glucose tablets or sugary snacks available in case of sudden hypoglycemia.\n\nPrecautions While Using Nateglinide 60mg Tablets\nFollow a Proper Diet\n\nMedication alone is not enough. A diabetes-friendly diet is essential for effective glucose control.\n\nExercise Regularly\n\nPhysical activity helps improve insulin sensitivity and overall health.\n\nMonitor Blood Sugar Levels\n\nRegular glucose monitoring helps track treatment effectiveness.\n\nAvoid Alcohol\n\nAlcohol may increase the risk of low blood sugar.\n\nInform Your Doctor About Other Medicines\n\nSome medications may interact with Nateglinide and affect blood sugar levels.\n\nDrug Interactions\n\nNateglinide may interact with:\n\nInsulin\nMetformin\nBeta-blockers\nAntifungal medicines\nSteroids\nCertain antibiotics\n\nAlways inform your healthcare provider about all medications and supplements you use.\n\nStorage Instructions\n\nStore Nateglinide 60mg Tablets:\n\nIn a cool and dry place\nAway from direct sunlight\nBelow recommended room temperature\nOut of reach of children\n\nDo not use expired medicines.\n\nLifestyle Tips for Better Diabetes Management\n\nTo achieve the best results with Nateglinide:\n\nEat meals on time\nReduce sugar intake\nStay physically active\nMaintain healthy body weight\nDrink enough water\nAvoid smoking\nGet regular health checkups\n\nCombining medication with healthy habits can significantly improve diabetes control.\n\nFrequently Asked Questions (FAQs)\nCan Nateglinide 60mg Tablets cure diabetes?\n\nNo, Nateglinide helps manage blood sugar levels but does not cure diabetes.\n\nWhen should I take Nateglinide?\n\nIt is generally taken before meals as directed by your doctor.\n\nCan I take Nateglinide with other diabetes medicines?\n\nYes, doctors often prescribe it with other anti-diabetic medications depending on individual needs.\n\nWhat happens if I miss a dose?\n\nIf you skip a meal, you may need to skip the dose. Consult your doctor for guidance.\n\nIs Nateglinide safe for long-term use?\n\nIt can be used long-term under proper medical supervision and regular monitoring.\n\nConclusion\n\nNateglinide 60mg Tablets are an effective solution for managing post-meal blood sugar spikes in patients with Type 2 Diabetes Mellitus. With its rapid action and flexible dosing schedule, it helps improve glucose control and supports healthier daily living.\n\nWhen combined with proper diet, exercise, and regular monitoring, Nateglinide can play an important role in long-term diabetes management. Always use this medication exactly as prescribed by your healthcare professional for the best results and safety.", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2432, "imageuri": "https://productimages.withfloats.com/actual/6a1974a2e30ab7df920848be.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a1974a2e30ab7df920848be.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-05-29T11:12:17.589Z", "updatedon": "2026-05-29T11:15:43.851Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nateglinide-60mg/2432", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NATIGLUMIDE 60", "category": "DIABETIC RANGE", "tags": [ "Nateglinide 60mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a153f150f3a1ec7df62ff41", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg", "description": "Glimepiride Voglibose and Metformin Hydrochloride Tablets are a combination anti-diabetic medicine used for the effective management of Type 2 Diabetes Mellitus. This triple-action formulation helps control blood sugar levels through multiple mechanisms, making it highly beneficial for patients who are unable to achieve adequate glucose control with single-drug therapy.\n\nType 2 diabetes is a chronic metabolic disorder that affects the body’s ability to regulate blood sugar properly. Uncontrolled diabetes can lead to severe health complications such as heart disease, kidney damage, nerve disorders, vision problems, and poor circulation. This combination therapy is designed to provide comprehensive glycemic control by improving insulin action, reducing glucose production, and slowing carbohydrate absorption.\n\nDoctors commonly prescribe Glimepiride Voglibose and Metformin Hydrochloride Tablets to support long-term diabetes management and reduce the risk of diabetes-related complications.\n\nWhat are Glimepiride Voglibose and Metformin Hydrochloride Tablets?\n\nThis medicine contains three active ingredients that work together to maintain healthy blood sugar levels:\n\nGlimepiride – A sulfonylurea anti-diabetic agent\nVoglibose – An alpha-glucosidase inhibitor\nMetformin Hydrochloride – A biguanide anti-diabetic medicine\n\nEach ingredient targets a different pathway involved in blood sugar regulation, offering a more effective approach for diabetes control.\n\nKey Benefits of Glimepiride Voglibose and Metformin Hydrochloride Tablets\n1. Helps Control Blood Sugar Levels Effectively\n\nThis combination medicine provides comprehensive glucose management throughout the day, especially after meals when blood sugar spikes are common.\n\n2. Improves Insulin Function\n\nGlimepiride stimulates the pancreas to release insulin, helping the body utilize glucose more efficiently.\n\n3. Reduces Excess Glucose Production\n\nMetformin decreases glucose production in the liver and improves insulin sensitivity, making it easier for the body to use available insulin.\n\n4. Controls Post-Meal Sugar Spikes\n\nVoglibose delays carbohydrate digestion and absorption in the intestine, helping prevent sudden increases in blood sugar after meals.\n\n5. Supports Long-Term Diabetes Management\n\nRegular use helps reduce the risk of complications associated with uncontrolled diabetes, such as kidney disease, nerve damage, and cardiovascular problems.\n\nHow Glimepiride Voglibose and Metformin Hydrochloride Tablets Work\n\nThis triple-drug combination works through complementary mechanisms:\n\nGlimepiride\n\nGlimepiride stimulates beta cells in the pancreas to release insulin. Increased insulin helps lower blood glucose levels by allowing sugar to enter body cells for energy use.\n\nVoglibose\n\nVoglibose inhibits enzymes responsible for breaking down complex carbohydrates into simple sugars. This slows glucose absorption from food and prevents rapid post-meal blood sugar rises.\n\nMetformin Hydrochloride\n\nMetformin reduces glucose production by the liver and enhances insulin sensitivity in muscles and tissues. It also helps decrease intestinal glucose absorption.\n\nTogether, these actions provide balanced and effective blood sugar control throughout the day.\n\nUses of Glimepiride Voglibose and Metformin Hydrochloride Tablets\n\nThis medicine is primarily prescribed for:\n\nType 2 Diabetes Mellitus\nPoorly controlled blood sugar levels\nPostprandial hyperglycemia (high blood sugar after meals)\nDiabetes management in overweight individuals\nCombination therapy when diet and exercise alone are insufficient\n\nIt is usually recommended along with proper diet, exercise, and lifestyle modifications.\n\nDosage and Administration\n\nThe dosage depends on blood sugar levels, patient response, and physician recommendations.\n\nGeneral Usage Guidelines\nUsually taken once or twice daily with meals\nSwallow tablets whole with water\nTake at the same time each day for consistent control\nFollow dietary advice strictly during treatment\n\nDo not skip meals while taking this medicine, as it may increase the risk of low blood sugar.\n\nPatients should regularly monitor blood glucose levels during therapy.\n\nPossible Side Effects\n\nLike any medication, Glimepiride Voglibose and Metformin Hydrochloride Tablets may cause side effects in some individuals.\n\nCommon Side Effects\nNausea\nDiarrhea\nAbdominal discomfort\nGas or bloating\nHeadache\nDizziness\nLow Blood Sugar Symptoms (Hypoglycemia)\n\nGlimepiride may occasionally cause low blood sugar, especially if meals are skipped.\n\nSymptoms include:\n\nSweating\nShaking\nHunger\nWeakness\nFast heartbeat\nConfusion\n\nKeeping a quick sugar source such as glucose tablets or juice is recommended.\n\nRare but Serious Side Effects\nSevere allergic reactions\nLactic acidosis (rare but serious with metformin)\nLiver-related issues\n\nImmediate medical attention should be sought if serious symptoms occur.\n\nPrecautions and Warnings\n\nBefore using this medicine, patients should inform their doctor about any existing medical conditions.\n\nImportant Precautions\nAvoid excessive alcohol consumption\nUse cautiously in kidney or liver disease\nRegular monitoring of kidney function may be required\nElderly patients may need dose adjustments\nInform the doctor before surgery or major illness\nPregnant or breastfeeding women should use only if prescribed\n\nMaintaining proper meal timing and lifestyle habits is important for safe and effective diabetes management.\n\nWho Should Use Glimepiride Voglibose and Metformin Hydrochloride Tablets?\n\nThis medicine is suitable for:\n\nAdults with Type 2 Diabetes Mellitus\nPatients with uncontrolled post-meal glucose levels\nIndividuals requiring combination anti-diabetic therapy\nPatients not achieving adequate control with single medicines\nOverweight diabetic individuals needing insulin sensitivity improvement\n\nA healthcare professional will determine the appropriate treatment plan based on medical history and glucose profile.\n\nWhy Choose Glimepiride Voglibose and Metformin Hydrochloride Tablets?\n\nThis combination therapy is preferred because it targets multiple aspects of diabetes simultaneously.\n\nAdvantages Include:\nTriple-action blood sugar control\nBetter post-meal glucose management\nImproved insulin utilization\nConvenient combination therapy\nReduces need for multiple separate medicines\nSupports long-term metabolic health\n\nIt offers comprehensive diabetes management in a single tablet formulation.\n\nLifestyle Tips for Better Diabetes Control\n\nAlong with medication, healthy lifestyle changes significantly improve diabetes management.\n\nRecommended Habits\nFollow a balanced diabetic diet\nExercise regularly\nMonitor blood sugar consistently\nMaintain healthy body weight\nAvoid smoking and excessive alcohol\nStay hydrated\nGet regular medical checkups\n\nThese habits help improve treatment effectiveness and reduce complications.\n\nStorage Instructions\nStore in a cool, dry place\nProtect from moisture and direct sunlight\nKeep out of reach of children\nUse only before expiry date\nBuyer Intent Summary\n\nIf you are searching for an effective combination medicine for Type 2 Diabetes management, Glimepiride Voglibose and Metformin Hydrochloride Tablets provide advanced blood sugar control through a triple-action mechanism. This medicine helps reduce fasting and post-meal sugar levels while improving insulin function and metabolic balance.", "price": 262.0, "discountamount": 79.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2428, "imageuri": "https://productimages.withfloats.com/actual/6a153f17d73bfed7b4b4181f.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a153f17d73bfed7b4b4181f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-05-26T06:35:01.356Z", "updatedon": "2026-05-26T06:35:01.356Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg/2428", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "DIABETIC RANGE", "tags": [ "glimepiride voglibose and metformin hydrochloride tablets", "metformin glimepiride voglibose", "glimepiride voglibose metformin", "tab metformin glimepiride voglibose", "glimepiride voglibose and metformin hydrochloride tablets uses", "metformin hydrochloride glimepiride voglibose", "metformin glimepiride voglibose 0.3", "glimepiride voglibose and metformin sr tablets", "glimepiride voglibose and metformin", "metformin glimepiride voglibose uses", "metformin glimepiride voglibose combination", "metformin glimepiride voglibose 0.2", "metformin glimepiride voglibose dose" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69affd814f6df2ce02d820ab", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Metformin Hydrochloride Prolonged Release", "description": "Metformin Hydrochloride Prolonged Release Tablets for Effective Blood Sugar Control\n\nManaging diabetes requires a combination of proper medication, a balanced lifestyle, and regular monitoring of blood glucose levels. For individuals living with type 2 diabetes, maintaining stable blood sugar levels is essential to prevent complications and ensure overall health. SEIZMET 500, formulated with Metformin Hydrochloride Prolonged Release, is a trusted oral medication designed to help control blood sugar levels in adults diagnosed with type 2 diabetes mellitus.\n\nSEIZMET 500 works by improving the body's response to insulin and reducing the amount of glucose produced by the liver. Its prolonged-release formulation allows the medicine to work gradually throughout the day, providing consistent blood sugar control while reducing gastrointestinal discomfort that may occur with immediate-release forms of metformin.\n\nThis medication is widely recommended by healthcare professionals as a first-line treatment for type 2 diabetes, especially for patients who need effective glycemic control along with long-term metabolic support.\n\nProduct Description\n\nSEIZMET 500 is an oral antidiabetic medication containing Metformin Hydrochloride in a prolonged-release formulation. Metformin belongs to a class of medicines known as biguanides, which are commonly prescribed to manage type 2 diabetes.\n\nUnlike many diabetes medications that stimulate the pancreas to produce more insulin, Metformin works through multiple mechanisms that improve the body’s natural ability to regulate blood sugar. It reduces excess glucose production in the liver, increases insulin sensitivity, and enhances the uptake of glucose by muscles and tissues.\n\nThe prolonged-release (PR) technology used in SEIZMET 500 ensures that the medicine is released slowly into the bloodstream over time. This gradual release helps maintain stable blood sugar levels throughout the day and minimizes sudden spikes or fluctuations in glucose levels.\n\nSEIZMET 500 is typically prescribed along with dietary modifications, exercise, and regular monitoring of blood glucose levels to achieve optimal diabetes management.\n\nComposition\n\nEach tablet of SEIZMET 500 contains:\n\nMetformin Hydrochloride Prolonged Release – 500 mg\n\nThis controlled-release formulation provides sustained therapeutic action and improved patient tolerance.\n\nUses of SEIZMET 500\n\nSEIZMET 500 is primarily used for the treatment and management of type 2 diabetes mellitus. It helps control blood sugar levels in individuals whose glucose levels cannot be adequately managed through lifestyle changes alone.\n\n1. Treatment of Type 2 Diabetes\n\nThe primary use of SEIZMET 500 is to manage elevated blood sugar levels in adults diagnosed with type 2 diabetes.\n\n2. Improving Glycemic Control\n\nThe medication helps regulate both fasting and post-meal blood glucose levels, improving overall glycemic stability.\n\n3. Supporting Insulin Sensitivity\n\nMetformin enhances the body's sensitivity to insulin, allowing cells to use glucose more effectively for energy.\n\n4. Prevention of Diabetes Complications\n\nBy maintaining proper blood sugar levels, SEIZMET 500 may help reduce the risk of complications such as nerve damage, kidney disease, vision problems, and cardiovascular conditions.\n\n5. Management of Insulin Resistance\n\nMetformin is known for its ability to reduce insulin resistance, which is a major factor contributing to type 2 diabetes.\n\nHow SEIZMET 500 Works\n\nSEIZMET 500 works through several mechanisms that help control blood glucose levels:\n\nReduces Liver Glucose Production\nThe liver produces glucose even when the body does not need it. Metformin helps decrease this excessive glucose production.\n\nImproves Insulin Sensitivity\nThe medication helps body tissues respond better to insulin, allowing glucose to enter cells more efficiently.\n\nEnhances Glucose Utilization\nMuscles and other tissues use glucose more effectively for energy.\n\nDecreases Intestinal Glucose Absorption\nMetformin slows down the absorption of glucose from the digestive tract after meals.\n\nThe prolonged-release technology ensures that these actions occur steadily throughout the day.\n\nKey Benefits of SEIZMET 500\n1. Effective Blood Sugar Control\n\nSEIZMET 500 helps maintain healthy blood glucose levels, reducing the risk of hyperglycemia.\n\n2. Sustained Drug Release\n\nThe prolonged-release formulation provides gradual drug release, ensuring consistent therapeutic effects.\n\n3. Lower Risk of Hypoglycemia\n\nUnlike some diabetes medications, metformin rarely causes dangerously low blood sugar when used alone.\n\n4. Improved Insulin Sensitivity\n\nSEIZMET 500 improves the body's response to insulin, allowing glucose to be used more efficiently.\n\n5. Supports Long-Term Diabetes Management\n\nRegular use helps maintain stable glucose levels and supports overall metabolic health.\n\n6. Reduced Gastrointestinal Side Effects\n\nThe prolonged-release formulation helps minimize stomach-related side effects commonly associated with immediate-release metformin.\n\n7. Weight-Neutral or Weight-Friendly\n\nMetformin may help prevent weight gain and in some cases may support mild weight reduction, which can benefit people with type 2 diabetes.\n\nHow to Use SEIZMET 500\n\nTo achieve the best results, SEIZMET 500 should be taken according to the instructions provided by a healthcare professional.\n\nGeneral usage guidelines include:\n\nTake the tablet with meals to reduce stomach discomfort.\n\nSwallow the tablet whole with water; do not crush, chew, or break the prolonged-release tablet.\n\nFollow the dosage and schedule prescribed by your doctor.\n\nMaintain a healthy diet and regular exercise routine.\n\nConsistency in taking the medication is essential for maintaining stable blood sugar levels.\n\nPossible Side Effects\n\nLike all medications, SEIZMET 500 may cause side effects in some individuals. Most side effects are mild and temporary, especially during the early stages of treatment.\n\nCommon Side Effects\n\nNausea\n\nDiarrhea\n\nStomach upset\n\nLoss of appetite\n\nMild abdominal discomfort\n\nThese symptoms often improve as the body adjusts to the medication.\n\nLess Common Side Effects\n\nMetallic taste in the mouth\n\nVitamin B12 deficiency with long-term use\n\nMild weakness or fatigue\n\nRare but Serious Side Effects\n\nLactic acidosis, a rare but serious condition associated with metformin use in patients with severe kidney problems\n\nSevere allergic reactions\n\nIf symptoms such as unusual muscle pain, difficulty breathing, severe weakness, or persistent vomiting occur, medical attention should be sought immediately.\n\nPrecautions\n\nBefore taking SEIZMET 500, inform your healthcare provider if you have:\n\nKidney disease\n\nLiver disorders\n\nHeart conditions\n\nSevere infections\n\nA history of alcohol abuse\n\nAdditional precautions include:\n\nAvoid excessive alcohol consumption.\n\nRegularly monitor blood sugar levels.\n\nAttend routine medical checkups.\n\nInform your doctor about any other medications you are taking.\n\nLifestyle Recommendations for Better Results\n\nMedication alone may not be enough to manage diabetes effectively. Individuals taking SEIZMET 500 should also focus on healthy lifestyle habits such as:\n\nMaintaining a balanced and nutritious diet\n\nEngaging in regular physical activity\n\nMonitoring blood sugar levels regularly\n\nMaintaining a healthy body weight\n\nFollowing medical advice and attending regular health checkups\n\nThese steps help maximize the benefits of the medication and support overall health.\n\nConclusion\n\nType 2 diabetes is a long-term condition that requires consistent management to maintain healthy blood sugar levels and prevent complications. SEIZMET 500, containing Metformin Hydrochloride Prolonged Release, offers an effective and reliable treatment option for individuals seeking better glucose control.", "price": 31.0, "discountamount": 9.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2324, "imageuri": "https://productimages.withfloats.com/actual/69affdab1344531582e8f29c.png", "tileimageuri": "https://productimages.withfloats.com/tile/69affdab1344531582e8f29c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-10T11:16:17.511Z", "updatedon": "2026-03-14T12:11:16.322Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//metformin-hydrochloride-prolonged-release/2324", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET 500", "category": "DIABETIC RANGE", "tags": [ "metformin hydrochloride prolonged release tablets", "metformin hydrochloride slow release tablets", "prolonged release metformin 500 mg tablets", "metformin hcl pr tablets for diabetes", "metformin hydrochloride controlled release tablet", "metformin hydrochloride 1000 mg prolonged release", "diabetes management tablets metformin prolonged release", "medicine for type 2 diabetes metformin pr tablets", "slow release metformin tablets for high blood sugar", "extended release metformin tablets for blood sugar management", "metformin hydrochloride extended release for insulin resistance", "buy metformin hydrochloride prolonged release tablets", "metformin pr tablets price", "SEIZMET 500 metformin hydrochloride prolonged release price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "698d91909e3c03f732124005", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Remogliflozin Etabonate Tablets 100 mg", "description": "REMOFLOZIN 100 is an advanced oral antidiabetic medication containing Remogliflozin Etabonate 100 mg as its active pharmaceutical ingredient. This innovative formulation represents a significant breakthrough in the management of Type 2 Diabetes Mellitus, offering patients a novel mechanism of action that works independently of insulin secretion or insulin sensitivity. REMOFLOZIN 100 belongs to the sodium-glucose co-transporter 2 (SGLT2) inhibitors class of medications, which has revolutionized diabetes management by targeting glucose reabsorption in the kidneys rather than affecting pancreatic function or peripheral glucose utilization.\nDeveloped through rigorous scientific research and clinical trials, REMOFLOZIN 100 provides diabetic patients with an effective therapeutic option that not only helps control blood sugar levels but also offers additional cardiovascular and metabolic benefits. Each tablet is precisely formulated to deliver consistent and reliable glycemic control, making it an essential component in the comprehensive management of Type 2 Diabetes.\nHow REMOFLOZIN 100 Works\nThe mechanism of action of REMOFLOZIN 100 is both unique and highly effective. Under normal physiological conditions, the kidneys filter glucose from the blood, but the SGLT2 proteins in the proximal renal tubules reabsorb approximately 90% of this filtered glucose back into the bloodstream. In diabetic patients, this reabsorption continues even when blood glucose levels are elevated, perpetuating hyperglycemia.\nRemogliflozin Etabonate works by selectively inhibiting the SGLT2 proteins in the kidneys, thereby reducing glucose reabsorption and increasing urinary glucose excretion. This insulin-independent mechanism allows the body to eliminate excess glucose naturally through urine, leading to sustained reductions in blood glucose levels. The medication typically begins working within hours of administration, with maximum therapeutic effects observed within several weeks of consistent use.\nPrimary Uses and Indications\nREMOFLOZIN 100 is primarily indicated for:\nManagement of Type 2 Diabetes Mellitus: As monotherapy in patients who cannot tolerate metformin or for whom metformin is contraindicated, and as combination therapy with other antidiabetic agents including metformin, sulfonylureas, or insulin when existing treatment regimens fail to achieve adequate glycemic control.\nGlycemic Control Optimization: For patients requiring additional blood sugar management beyond diet and exercise modifications, REMOFLOZIN 100 helps reduce both fasting plasma glucose and postprandial glucose levels.\nAdjunct to Lifestyle Modifications: The medication works synergistically with dietary modifications and regular physical activity to achieve comprehensive diabetes management and reduce the risk of long-term diabetic complications.\nKey Benefits of REMOFLOZIN 100\nSuperior Glycemic Control\nREMOFLOZIN 100 demonstrates significant efficacy in reducing HbA1c levels, typically achieving reductions of 0.5% to 1.0% when used as monotherapy and even greater reductions when combined with other antidiabetic medications. This improvement in long-term glucose control translates to reduced risk of microvascular complications, including diabetic retinopathy, nephropathy, and neuropathy.\nWeight Management Support\nUnlike many traditional antidiabetic medications that may cause weight gain, REMOFLOZIN 100 is associated with modest weight loss, typically ranging from 2 to 4 kilograms over several months of treatment. This weight reduction occurs due to caloric loss through urinary glucose excretion and may provide additional metabolic benefits for overweight or obese diabetic patients.\nCardiovascular Benefits\nEmerging research on SGLT2 inhibitors suggests potential cardiovascular protective effects, including modest reductions in blood pressure and improvements in various cardiovascular risk markers. These benefits may be particularly valuable for diabetic patients who are at increased risk of cardiovascular disease.\nLow Risk of Hypoglycemia\nBecause REMOFLOZIN 100 works independently of insulin secretion, it carries a minimal risk of hypoglycemia when used as monotherapy. This safety profile makes it particularly suitable for elderly patients or those at higher risk of dangerous low blood sugar episodes.\nRenal Function Considerations\nThe medication may offer nephroprotective benefits by reducing intraglomerular pressure and proteinuria in diabetic patients, potentially slowing the progression of diabetic kidney disease.\nConvenient Once-Daily Dosing\nREMOFLOZIN 100's pharmacokinetic profile allows for convenient once-daily administration, improving patient compliance and treatment adherence.\nPotential Side Effects and Safety Considerations\nWhile REMOFLOZIN 100 is generally well-tolerated, patients should be aware of potential side effects:\nCommon Side Effects\n\nGenital Mycotic Infections: Increased glucose in urine may promote fungal infections, particularly in women\nUrinary Tract Infections: More frequent urination and glucose in urine may increase UTI risk\nIncreased Urination: Polyuria is expected due to the medication's mechanism of action\nThirst: Patients may experience increased thirst due to fluid loss\nDizziness: Particularly when standing up quickly, due to mild blood pressure reductions\n\nSerious but Rare Side Effects\n\nDiabetic Ketoacidosis: Although rare, euglycemic DKA has been reported with SGLT2 inhibitors\nAcute Kidney Injury: Dehydration may affect kidney function in susceptible individuals\nLower Limb Amputation: Some SGLT2 inhibitors have shown increased risk in specific populations\nHypotension: Particularly in patients on diuretics or with compromised cardiovascular function\n\nContraindications and Precautions\nREMOFLOZIN 100 should not be used in patients with type 1 diabetes, severe renal impairment, diabetic ketoacidosis, or those with known hypersensitivity to the drug. Pregnant and breastfeeding women should avoid this medication. Patients should maintain adequate hydration and practice proper genital hygiene to minimize infection risks.\nDosage and Administration Guidelines\nThe standard recommended dose is one REMOFLOZIN 100 tablet taken orally once daily, preferably at the same time each day. The medication can be taken with or without food. Patients should not double doses if they miss a scheduled dose but should take the next dose at the regular time. Dosage adjustments may be necessary based on individual response, renal function, and concomitant medications. Regular monitoring of blood glucose levels, kidney function, and HbA1c is essential for optimal treatment management.\nConclusion\nREMOFLOZIN 100 represents a valuable therapeutic advancement in type 2 diabetes management, offering patients an innovative approach to glycemic control through its unique renal mechanism of action. The medication's ability to reduce blood sugar levels while providing additional benefits such as weight loss, cardiovascular protection, and low hypoglycemia risk makes it an attractive option for many diabetic patients.", "price": 335.0, "discountamount": 101.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2301, "imageuri": "https://productimages.withfloats.com/actual/698d9191cd6033ecce84b352.png", "tileimageuri": "https://productimages.withfloats.com/tile/698d9191cd6033ecce84b352.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-12T08:38:40.037Z", "updatedon": "2026-03-13T11:02:30.281Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//remogliflozin-etabonate-tablets-100-mg/2301", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "REMOFLOZIN 100", "category": "DIABETIC RANGE", "tags": [ "Remogliflozin Etabonate 100mg tablets for type 2 diabetes", "Remogliflozin 100mg oral diabetes medication", "Remogliflozin Etabonate tablets 100mg prescription", "Remogliflozin 100 mg SGLT2 inhibitor tablets", "Remogliflozin Etabonate 100mg diabetes control tablets", "Buy Remogliflozin 100mg tablets online", "Remogliflozin Etabonate 100mg pack price", "Remogliflozin 100mg tablets for blood sugar management" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694e56c05837f90c86a7eb8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin linagliptin and metformin", "description": "LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short.\n​\n\nProduct Description and Composition\nLINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk.\n​\n\nThis unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically.\n​\n\nMechanism of Action\nThe triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake.\n​\n\nSynergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance.\n​\n\nUses and Indications\nLINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy.\n​\n\nPrescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation.\n​\n\nKey Benefits\nLINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management:\n\nSuperior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects.\n​\n\nWeight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect.\n​\n\nCardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes.\n​\n\nLow Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas.\n​\n\nConvenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond.\n​\n\nBlood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg.\n​\n\nThese benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs.\n\nSide Effects\nCommon side effects mirror individual components but occur less due to synergy:\n\nGastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly.\n​\n\nGenitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene.\n​\n\nVolume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics.\n​\n\nSerious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation.\n​\n\nSide Effect Category\tFrequency\tManagement\nNausea and Diarrhea\tCommon (10%)\tTake with food, slow titration \n​\nUTI/Mycotic Infections\tCommon (7%)\tHydration, antifungals \n​\nHypoglycemia\tRare (<2%)\tWith insulin, dose adjust \n​\nLactic Acidosis\tVery Rare.\tAvoid in renal/hepatic failure \n​\nKetoacidosis\tRare (0.1%)\tCheck ketones if nausea \n​\nDosage and Administration\nStart with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity.\n​\n\nMissed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use.\n\nPrecautions and Warnings\nAssess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated.\n​\n\nDrug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure.\n\nFrequently Asked Questions\nWhat is LINALIGIP EMPAMET used for?\nControls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity.\n​\nDoes it cause weight gain?\nNo—it promotes 2-4 kg loss, unlike some antidiabetics.\n​\n\nSafe for kidneys?\nRenal-protective; monitor eGFR.\n​\n\nHypoglycemia risk?\nMinimal without sulfonylureas.\n\nConclusion\nLINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.", "price": 220.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2257, "imageuri": "https://productimages.withfloats.com/actual/694e60c1db6d50f75e42e875.png", "tileimageuri": "https://productimages.withfloats.com/tile/694e60c1db6d50f75e42e875.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-26T09:34:56.604Z", "updatedon": "2026-03-13T10:59:31Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-linagliptin-and-metformin/2257", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGIP EMPAMET", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 10 mg", "empagliflozin 25 mg", "empagliflozin 10 mg uses in hindi", "empagliflozin 10 mg tablet.", "type 2 diabetes mellitus.", "linagliptin", "Linagliptin 5 mg", "linagliptin 5 mg uses", "linagliptin tablet uses", "Linagliptin 5 mg price", "Empagliflozin, an SGLT2 inhibitor.", "Metformin ER reduces hepatic glucose production and improves insulin.", "LINALIGIP EMPAMET revolutionizes type 2 diabetes.", "empagliflozin linagliptin and metformin tablets", "empagliflozin linagliptin metformin combination tablet", "empagliflozin linagliptin metformin tablets uses", "empagliflozin linagliptin metformin triple combination", "empagliflozin linagliptin metformin dosage strength", "empagliflozin linagliptin metformin sustained release tablet", "empagliflozin linagliptin metformin medicine for diabetes", "empagliflozin linagliptin metformin tablet uses", "empagliflozin linagliptin metformin benefits", "empagliflozin linagliptin metformin for type 2 diabetes", "empagliflozin linagliptin metformin blood sugar control", "empagliflozin linagliptin metformin weight loss benefit", "what is empagliflozin linagliptin metformin tablet", "how does empagliflozin linagliptin metformin work", "empagliflozin linagliptin metformin tablet price in india", "empagliflozin linagliptin metformin tablet dosage", "empagliflozin linagliptin metformin before or after food" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69282c091a6e5ed700f07fe1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Lurasidone Hydrochloride Tablets 40 mg", "description": "Lurasidone Hydrochloride Tablets 40 mg are an atypical antipsychotic medication primarily prescribed for the treatment of schizophrenia and bipolar disorder, including depressive episodes associated with bipolar I disorder. Manufactured to deliver precise dosing, these tablets help manage symptoms such as hallucinations, delusions, mood swings, and depression by modulating the activity of certain neurotransmitters in the brain. Lurasidone works by balancing dopamine and serotonin receptors, which are often dysregulated in psychiatric conditions, thereby improving thought processes, mood stability, and overall mental function.\nKey Benefits of Lurasidone Hydrochloride Tablets 40 mg\nEffective control of schizophrenia symptoms such as delusions, hallucinations, and disorganized thinking.\nTreatment of major depressive episodes in bipolar I disorder either as monotherapy or adjunctive therapy with lithium or valproate.\nImprovement in mood stabilization helps reduce manic and depressive episodes in bipolar patients.\nGenerally improved patient quality of life by reducing the severity of psychotic and mood symptoms.\nSuitable for adult patients as well as adolescents aged 13 years and older for schizophrenia and patients 10 years and older for bipolar depression under medical guidance.\nFlexible dosing options allow for titration based on clinical response and tolerability.\nSide Effects of Lurasidone Hydrochloride Tablets 40 mg\nLike many antipsychotic medications, Lurasidone may cause side effects, some of which are mild and manageable, while others may require medical attention. Common side effects include nausea, dizziness, restlessness, sedation, weight gain, and gastrointestinal issues such as vomiting or constipation. Some patients may experience extrapyramidal symptoms, which affect muscle control and movement, such as tremors or rigidity. Blood sugar and lipid levels may rise, so periodic monitoring is advised.\nSerious side effects, though less common, can include neuroleptic malignant syndrome (a rare but severe neurological disorder), tardive dyskinesia (involuntary muscle movements), and metabolic changes like significant weight gain, hyperglycemia, or elevated cholesterol. Allergic reactions are rare but possible and require immediate medical attention.\n\nConclusion\n\nLurasidone Hydrochloride Tablets 40 mg offer significant benefits for patients struggling with schizophrenia and bipolar depression by addressing psychotic symptoms and mood disturbances through targeted neurotransmitter modulation. Its efficacy in improving mental health and quality of life is well-documented, but careful adherence to prescribed dosages and medical supervision are essential due to potential side effects. Regular monitoring and open communication with healthcare providers help ensure that patients receive the maximum therapeutic benefit while minimizing risks. This medication should always be used under the guidance of a qualified healthcare professional.", "price": 280.0, "discountamount": 84.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2222, "imageuri": "https://productimages.withfloats.com/actual/69282c0bb521bb4f16017ce2.png", "tileimageuri": "https://productimages.withfloats.com/tile/69282c0bb521bb4f16017ce2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-27T10:46:33.864Z", "updatedon": "2026-03-13T07:44:39.591Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//lurasidone-hydrochloride-tablets-40-mg/2222", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LURASINODE 40", "category": "NEUROLOGY RANGE", "tags": [ "Lurasidone Hydrochloride Tablets 40 mg", "schizophrenia and bipolar disorder", "Lurasidone", "bipolar I disorder", "lurasidone hydrochloride tablets 40 mg", "lurasidone 40 mg tablets", "lurasidone hydrochloride 40 mg tablet", "lurasidone hydrochloride tablet strength 40 mg", "lurasidone hydrochloride tablets 40 mg uses", "lurasidone 40 mg tablet benefits", "how to take lurasidone hydrochloride 40 mg", "lurasidone hydrochloride 40 mg tablet details", "lurasidone 40 mg tablet composition", "lurasidone hydrochloride tablets 40 mg working mechanism", "lurasidone hydrochloride tablets 40 mg price", "lurasidone 40 mg tablet cost in india", "lurasidone hydrochloride 40 mg tablet manufacturer", "lurasidone hydrochloride tablets 40 mg supplier", "lurasidone hydrochloride tablets 40 mg india", "lurasidone 40 mg tablet wholesale", "lurasidone hydrochloride tablets exporter india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6911af10f122e2a45d230b07", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg & Glimepirde 2 mg", "description": "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 2 mg is a triple-combination oral anti-diabetic medication formulated to achieve optimal blood sugar control in adults with Type 2 Diabetes Mellitus (T2DM). This unique blend brings together three complementary agents — Sitagliptin (a DPP-4 inhibitor), Metformin (a biguanide), and Glimepiride (a sulfonylurea) — that work through distinct mechanisms to enhance glucose regulation, improve insulin sensitivity, and support overall metabolic balance.\n\nThis advanced combination therapy is prescribed when monotherapy or dual therapy fails to achieve adequate glycemic control. It helps reduce both fasting plasma glucose (FPG) and postprandial glucose (PPG) levels, promoting stable long-term glycemic management.\n\nUses of Sitagliptin + Metformin + Glimepiride\n\nThis fixed-dose combination is primarily indicated for the management of Type 2 Diabetes Mellitus in adults. It is especially beneficial for patients whose blood sugar levels remain uncontrolled despite treatment with Metformin and Glimepiride or Metformin and Sitagliptin alone.\n\nIts main objectives include:\n\nControlling elevated blood glucose levels in adults with Type 2 diabetes\n\nReducing the risk of diabetes-related complications such as neuropathy, nephropathy, and cardiovascular diseases\n\nSupporting better insulin utilization by the body\n\nComplementing diet, exercise, and lifestyle modification to maintain optimal glycemic balance\n\nMechanism of Action\n\nEach component of this combination plays a vital role in maintaining blood sugar control:\n\nSitagliptin (50 mg) – A Dipeptidyl Peptidase-4 (DPP-4) inhibitor that enhances the activity of incretin hormones. These hormones stimulate insulin release and suppress glucagon production when blood glucose levels rise, thereby improving post-meal glucose control.\n\nMetformin Hydrochloride (1000 mg) – A biguanide that lowers glucose production in the liver and increases the body’s sensitivity to insulin. It also decreases intestinal glucose absorption, making it an essential first-line therapy in diabetes management.\n\nGlimepiride (2 mg) – A sulfonylurea that stimulates pancreatic beta cells to release more insulin, especially when blood glucose levels are high. It works synergistically with Metformin and Sitagliptin for more effective glycemic control.\n\nKey Benefits\n\nTriple Mechanism for Superior Control:\nBy combining three potent agents, the medication addresses multiple pathways of glucose regulation—insulin secretion, insulin sensitivity, and hepatic glucose output—resulting in comprehensive and consistent control of blood sugar levels.\n\nEffective Glycemic Stability:\nThe combination helps maintain target HbA1c levels and reduces both fasting and post-meal glucose spikes without significant weight gain when used with proper diet and exercise.\n\nReduced Risk of Diabetic Complications:\nLong-term blood sugar control minimizes the risk of complications such as kidney disease, vision problems, nerve damage, and heart conditions associated with uncontrolled diabetes.\n\nConvenient Fixed-Dose Formulation:\nCombining three medications into a single tablet simplifies dosing schedules, improves patient adherence, and reduces pill burden, which is crucial for long-term treatment success.\n\nImproved Insulin Efficiency:\nEnhances the body's natural insulin response and glucose metabolism, allowing for smoother daily energy levels and reduced fatigue associated with hyperglycemia.\n\nPossible Side Effects\n\nWhile this combination is generally well tolerated, some patients may experience side effects, especially at the beginning of therapy. Common and rare side effects include:\n\nHypoglycemia (low blood sugar): More likely when meals are skipped or during excessive physical exertion. Symptoms include sweating, dizziness, and rapid heartbeat.\n\nGastrointestinal disturbances: Such as nausea, vomiting, diarrhea, abdominal discomfort, or loss of appetite (mostly due to Metformin).\n\nHeadache or Weakness: Usually mild and transient.\n\nAllergic reactions: Rarely, rash or itching may occur.\n\nLactic Acidosis (rare but serious): A potential complication of Metformin, particularly in patients with kidney impairment or excessive alcohol consumption.\n\nWeight gain: Mild weight gain may occur due to Glimepiride’s insulin-enhancing effect.\n\nPrecautions:\n\nRegular monitoring of blood sugar levels and kidney function is essential.\n\nAvoid alcohol and consult a doctor before using this medicine if you have liver or kidney disease.\n\nThe medication should not be used in patients with Type 1 diabetes or diabetic ketoacidosis.\n\nConclusion\n\nThe combination of Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 2 mg represents a powerful and balanced therapy for adults with Type 2 Diabetes Mellitus, especially those requiring triple-drug intervention to achieve desired glycemic control. Its multi-targeted approach ensures effective management of both fasting and postprandial glucose levels, thereby improving long-term metabolic health and reducing the risk of complications.", "price": 295.0, "discountamount": 89.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2197, "imageuri": "https://productimages.withfloats.com/actual/6911af137e4c90e1dc453884.png", "tileimageuri": "https://productimages.withfloats.com/tile/6911af137e4c90e1dc453884.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-10T09:23:28.795Z", "updatedon": "2026-03-13T10:41:32.995Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-50-mg-metformin-hydrochloride-1000-mg-glimepirde-2-mg/2197", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM 50+1000+2 ", "category": "DIABETIC RANGE", "tags": [ "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 2 mg", "anti-diabetic medication", "blood sugar control", "Type 2 Diabetes Mellitus" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "glimepiride voglibose metformin", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/69abe998ad5b8f3f9ba863c2.png", "tileimageuri": "https://productimages.withfloats.com/tile/69abe998ad5b8f3f9ba863c2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2026-03-13T10:35:41.824Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glimepiride-voglibose-metformin/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "DIABETIC RANGE", "tags": [ "glimepiride voglibose metformin tablets", "glimepiride voglibose metformin combination", "glimepiride voglibose metformin dosage", "glimepiride voglibose metformin uses", "glimepiride voglibose metformin composition", "glimepiride voglibose metformin tablets ip", "glimepiride voglibose metformin triple combination", "glimepiride voglibose metformin for type 2 diabetes", "triple drug combination for type 2 diabetes", "diabetes medicine for high fasting and pp sugar", "medicine for uncontrolled diabetes type 2", "combination tablets for diabetes management", "combination tablets for diabetes management", "when to take glimepiride voglibose metformin tablets", "who should take glimepiride voglibose metformin", "benefits of glimepiride voglibose metformin tablets", "side effects of glimepiride voglibose metformin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "680f67727d2a43891e570ff9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Benfotiamine, Alpha Lipoic Acid, Inositol, Mecobalamin, Folic Acid, Chromium and Selenium Capsules", "description": "Step into a new era of nutritional wellness with BENOTIAMINE PLUS CAPSULES, a specially crafted formula designed to support nerve function, enhance metabolic health, and strengthen the body’s natural antioxidant defenses. Powered by a synergistic blend of Benfotiamine, Alpha Lipoic Acid, Inositol, Mecobalamin, Folic Acid, Chromium, and Selenium, these capsules deliver comprehensive protection and nourishment, especially for individuals dealing with nerve discomfort, diabetes-related complications, and oxidative stress.\n\nKey Ingredients\nBenfotiamine: A highly bioavailable derivative of Vitamin B1 that penetrates nerve cells effectively, shielding them from glucose-induced damage.\n\nAlpha Lipoic Acid: A universal antioxidant that revitalizes other antioxidants, supports nerve health, and improves insulin sensitivity.\n\nInositol: A key molecule involved in nerve signaling and healthy cell function.\n\nMecobalamin (Methylcobalamin): The neurologically active form of Vitamin B12 crucial for nerve repair and regeneration.\n\nFolic Acid: Essential for DNA synthesis, cardiovascular protection, and nerve health maintenance.\n\nChromium: Supports glucose metabolism and enhances insulin action, promoting balanced blood sugar levels.\n\nSelenium: A powerful antioxidant that defends cells against oxidative injury and supports immune system resilience.\n\nKey Benefits\nSupports Nerve Regeneration: Promotes healthy nerve structure and function, reducing symptoms of neuropathy.\n\nStrengthens Antioxidant Shield: Fights harmful free radicals to protect nerves and vital tissues from oxidative stress.\n\nBoosts Metabolic Health: Aids in effective carbohydrate metabolism and energy production.\n\nRegulates Blood Sugar: Helps maintain healthy blood glucose levels, crucial for diabetics and pre-diabetics.\n\nEnhances Cardiovascular and Immune Health: Folic Acid and Selenium work synergistically to promote heart and immune system performance.\n\nOverall Vitality Boost: Supports energy levels, mood balance, and overall cellular health.\n\nHow Does It Work?\nBENOTIAMINE PLUS CAPSULES work by targeting the root causes of nerve and metabolic dysfunction:\n\nBenfotiamine protects nerve cells from high-glucose damage by preventing the formation of harmful advanced glycation end-products (AGEs).\n\nAlpha Lipoic Acid improves nerve blood flow and revives exhausted antioxidant defenses.\n\nMecobalamin and Inositol actively contribute to nerve repair and optimal signal transmission.\n\nChromium assists in the management of blood sugar, reducing oxidative stress linked to hyperglycemia.\n\nSelenium provides cellular defense, reducing inflammation and oxidative injury.\n\nThis multi-targeted action supports comprehensive nerve, metabolic, and antioxidant health, ensuring stronger protection and faster recovery.\n\nDirections for Use\nRecommended Dose: Take one capsule once or twice daily or as advised by your physician.\n\nAdministration: Best taken after meals with a glass of water.\n\nConsistency: For maximum benefit, it is important to take the capsules regularly and maintain a healthy diet and lifestyle alongside supplementation.\n\nSide Effects\nBENOTIAMINE PLUS CAPSULES are generally safe and well-tolerated. Rarely, some users may experience:\nMild gastrointestinal upset (such as bloating or diarrhea)\nAllergic reactions (rash, itching, or redness)\nLightheadedness or headache (very uncommon)\nAlways consult your healthcare provider if you experience any unexpected symptoms, or before starting if you have underlying health conditions.", "price": 214.0, "discountamount": 64.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "capsules regularly", "work benotiamine", "nerve repair", "nerve signaling", "capsules work", "healthcare provider", "redness lightheadedness", "welltolerated rarely", "generally safe", "healthy diet", "maximum benefit", "water consistency", "physician administration", "recommended dose", "hyperglycemia selenium", "highglucose damage", "promote heart", "vital tissues", "protect nerves", "oxidative injury", "defends cells", "powerful antioxidant", "universal antioxidant", "individuals dealing", "synergistic blend", "nutritional wellness", "unexpected symptoms", "cellular health", "vitamin b1", "selenium work synergistically", "underlying health conditions", "function reducing symptoms", "vitamin b12 crucial", "faster recovery directions", "inositol actively contribute", "immune system performance", "prediabetics enhances cardiovascular", "effective carbohydrate metabolism", "neurologically active form", "key molecule involved", "highly bioavailable derivative" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2092, "imageuri": "https://productimages.withfloats.com/actual/6926994a164c2f9b29acdd0f.png", "tileimageuri": "https://productimages.withfloats.com/tile/6926994a164c2f9b29acdd0f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-04-28T11:33:06.87Z", "updatedon": "2026-03-14T11:52:37.388Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//benfotiamine-alpha-lipoic-acid-inositol-mecobalamin-folic-acid-chromium-and-selenium-capsules/2092", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BENOTIAMINE PLUS CAPSULES", "category": "DIABETIC RANGE", "tags": [ "Benfotiamine", "Alpha Lipoic Acid", "Inositol", "Mecobalamin", "Folic Acid", "Chromium and Selenium Capsules" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }